Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining a supplementary protection certificate – Medicinal product having obtained a valid marketing authorisation – First authorisation – Product successively authorised as a veterinary medicinal product and a human medicinal product
Citations:
[2012] EUECJ C-130/11, [2013] RPC 23
Links:
Jurisdiction:
England and Wales
Citing:
Order – Neurim Pharmaceuticals v Comptroller-General of Patents ECJ 3-May-2012
(Order) Medicinal products for human use – Supplementary protection certificate – Regulation (EEC) No 1768/92 – Article 3 – Conditions for obtaining supplementary protection certificates – First authorisation to place a product on the market in the . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 26 April 2022; Ref: scu.675733